Ignite Creation Date:
2024-05-05 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00133900
Status:
UNKNOWN
Last Update Posted:
2009-07-28
First Post:
2005-08-22
Brief Title:
Circulating Tumor Cells and Survival in Hormone Refractory Prostate Cancer HRPC Patients Receiving Chemotherapy
Sponsor:
Immunicon
Organization:
Immunicon
Organization Data
Organization:
Immunicon
Class:
INDUSTRY
Study ID:
IMMC-38
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Immunicon
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Senior Director Clinical Development
Old Organization:
Immunicon